ClearPoint Neuro Inc (CLPT)
6.37
+0.36
(+5.99%)
USD |
NASDAQ |
May 15, 15:38
ClearPoint Neuro Enterprise Value: 139.41M for May 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 139.41M |
| May 13, 2024 | 135.02M |
| May 10, 2024 | 135.29M |
| May 09, 2024 | 142.15M |
| May 08, 2024 | 138.86M |
| May 07, 2024 | 136.12M |
| May 06, 2024 | 137.49M |
| May 03, 2024 | 135.57M |
| May 02, 2024 | 125.97M |
| May 01, 2024 | 123.23M |
| April 30, 2024 | 123.48M |
| April 29, 2024 | 120.74M |
| April 26, 2024 | 118.82M |
| April 25, 2024 | 120.19M |
| April 24, 2024 | 120.47M |
| April 23, 2024 | 125.40M |
| April 22, 2024 | 125.67M |
| April 19, 2024 | 120.74M |
| April 18, 2024 | 122.38M |
| April 17, 2024 | 126.22M |
| April 16, 2024 | 127.59M |
| April 15, 2024 | 128.42M |
| April 12, 2024 | 133.90M |
| April 11, 2024 | 144.59M |
| April 10, 2024 | 143.50M |
| Date | Value |
|---|---|
| April 09, 2024 | 149.53M |
| April 08, 2024 | 146.79M |
| April 05, 2024 | 150.90M |
| April 04, 2024 | 149.53M |
| April 03, 2024 | 155.56M |
| April 02, 2024 | 151.45M |
| April 01, 2024 | 159.12M |
| March 31, 2024 | 161.04M |
| March 28, 2024 | 170.88M |
| March 27, 2024 | 168.72M |
| March 26, 2024 | 163.84M |
| March 25, 2024 | 169.26M |
| March 22, 2024 | 164.66M |
| March 21, 2024 | 171.42M |
| March 20, 2024 | 176.30M |
| March 19, 2024 | 175.75M |
| March 18, 2024 | 178.19M |
| March 15, 2024 | 179.69M |
| March 14, 2024 | 181.31M |
| March 13, 2024 | 180.23M |
| March 12, 2024 | 150.02M |
| March 11, 2024 | 149.48M |
| March 08, 2024 | 153.79M |
| March 07, 2024 | 150.29M |
| March 06, 2024 | 155.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
35.47M
Minimum
Jun 25 2019
504.59M
Maximum
Feb 16 2021
181.56M
Average
162.94M
Median
Enterprise Value Benchmarks
| icad Inc | 19.97M |
| Perspective Therapeutics Inc | 1.025B |
| Xtant Medical Holdings Inc | 122.50M |
| Asensus Surgical Inc | 54.79M |
| Catheter Precision Inc | 3.117M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.146M |
| Revenue (Quarterly) | 7.639M |
| Total Expenses (Quarterly) | 11.87M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 59.24% |
| Profit Margin (Quarterly) | -54.27% |
| Earnings Yield | -13.19% |
| Normalized Earnings Yield | -13.19 |